Mitomycin C in anterior chamber tube shunt to a surgical membrane

1993 ◽  
Vol 7 (2) ◽  
pp. 48 ◽  
Author(s):  
Woong San Choi ◽  
Seok Joon Park ◽  
Dong Myung Kim
2021 ◽  
Vol 259 (3) ◽  
pp. 801-801
Author(s):  
Mario Montelongo ◽  
Francesc March de Ribot ◽  
Earl Randy Craven ◽  
William Eric Sponsel
Keyword(s):  

Ophthalmology ◽  
1985 ◽  
Vol 92 (4) ◽  
pp. 553-562 ◽  
Author(s):  
Stanley S. Schocket ◽  
Verinder S. Nirankari ◽  
Vinod Lakhanpal ◽  
Richard D. Richards ◽  
Brian C. Lerner

Author(s):  
Megan M. Geloneck ◽  
Robert M. Feldman

Although medical therapy is usually an excellent therapeutic option in the adult population, in children it is often ineffective or associated with an undesirable risk:benefit ratio. Therefore, surgical intervention is frequently required for adequate control of glaucoma in young patients. The initial surgical approach for management of glaucoma in children includes goniotomy and trabeculotomy, each with a high success rate. When these interventions fail or have a high likelihood of failure (i.e., in patients with Sturge-Weber syndrome, aniridia, anterior chamber dysgenesis, or congenital glaucoma), tube shunt procedures are often required. Tube shunts were first used in the pediatric population by Molteno and colleagues in 1973 and have since grown in popularity and secured an integral role in the treatment of refractory glaucoma in infants and children. Possible complications and causes for failure of tube shunt devices in children are very similar to those in adults; however, issues such as tube migration and retraction must be anticipated in the child’s growing eye. One of the most frustrating, and unfortunately the most common, complications is tube malposition. While tube malposition is not entirely specific to the pediatric population, it occurs far more frequently in children than in adults. (See Chapter 30 for information about tube malposition in adults.) Incidence of tube malposition in pediatric patients ranges from 3% to 35%. In infants and young children, the tube tends to retract from the eye and/or migrate towards the cornea in the anterior chamber. The initial presentation of tube migration is often tube-cornea touch at the proximal end of the tube near the insertion site. In severe cases, tube migration can lead to transcorneal extrusion of the tube. Secondary complications, including corneal decompensation, cataract, iris abnormalities, and endophthalmitis, can result from these initial insults if tube malposition is not identified early and appropriately addressed. The cause of tube migration and retraction is likely multifactorial, but there are 2 basic mechanisms thought to be at fault: 1) somatic growth causing concomitant tube migration and 2) elasticity of the buphthalmic eye, allowing shrinkage as intraocular pressure (IOP) decreases and tube straightening due to “memory.”


Author(s):  
Alan D. Penman ◽  
Kimberly W. Crowder ◽  
William M. Watkins

The Tube Versus Trabeculectomy (TVT) Study was a randomized clinical trial comparing tube shunt surgery to trabeculectomy with mitomycin C in patients with uncontrolled glaucoma (intraocular pressure (IOP) ≥18 mm Hg and ≤40 mm Hg on maximum tolerated medical therapy) who had previously undergone cataract extraction with intraocular lens implantation and/or failed filtering surgery. The study did not demonstrate clear superiority of one glaucoma operation over the other, but indicated that both tube shunt surgery and trabeculectomy with mitomycin C were viable surgical options for treating medically uncontrolled glaucoma in this group of patients. Both procedures were associated with similar IOP reduction and use of supplemental medical therapy at 5 years. Additional glaucoma surgery was needed more frequently after trabeculectomy with MMC than tube shunt placement.


2004 ◽  
Vol 35 (3) ◽  
pp. 189-196 ◽  
Author(s):  
Inci Irak ◽  
Marlene R Moster ◽  
Joann Fontanarosa

2018 ◽  
Vol 29 (4) ◽  
pp. NP9-NP12 ◽  
Author(s):  
Omneya Abdalrahman ◽  
Alejandra E Rodriguez ◽  
Jorge L Alio Del Barrio ◽  
Jorge L Alio

Purpose: To report a new approach for the treatment of severe ocular hypotony secondary to glaucoma filtering surgery with mitomycin C by injecting autologous eye platelet-rich plasma (E-PRP) in the anterior chamber to block excessive diffuse filtration through an abnormally thinned sclera. Methods: A 49-year-old patient with the Axenfeld–Rieger syndrome and severe chronic hypotony and corneal edema following filtering glaucoma surgery with mitomycin C received an isolated injection of 0.3 mL of autologous platelet-rich plasma in the anterior chamber. Results: Intraocular pressure measured by Goldman’s applanation tonometry 6 h after the procedure improved to 18 mmHg. Intraocular pressure remained stable along the full follow-up period of 6 month. No filtration or hypotony or any other complications were observed. Conclusion: Intracameral platelet-rich plasma (E-PRP) injection was an effective, rapidly effective, and safe procedure for treatment of severe chronic ocular hypotony following glaucoma filtrating surgery.


Author(s):  
Nan Wang

Tube shunts can be placed in the anterior chamber, the ciliary sulcus, or the pars plana. However, if the eye is phakic, the choice is limited to the anterior chamber; ciliary sulcus placement is likely to result in cataract formation, and pars plana placement will likely complicate removal of the cataract that will likely develop. Most corneal complications of tube shunt surgery result from tubes that are too anterior. Loss of vision may result due to these complications. If the tube is inadvertently inserted too close to the cornea, a loss of endothelial cells will result in edema and require transplantation to restore vision. Reported rates of corneal complications range from 2% to 33% and consist mostly of corneal edema/decompensation and corneal graft failure. In a cohort of patients implanted with the Ahmed™ Glaucoma Valve (New World Medical, Inc., Rancho Cucamonga, California), postoperative corneal abrasions occurred in 5 of 60 (8%) eyes. Another study reported the rate of corneal drying/dellen later in the postoperative course (8 of 59 eyes; 13.6%). Contact between the tube and the cornea has been noted at a rate of up to 5%. As the rate of tube shunt implantation has increased, the incidence of corneal edema in patients with tube shunts has also increased. Some of these cases develop corneal opacification with decreased vision and may require corneal transplantation to clear the visual axis. One large study of patients with Ahmed tube shunts (159 eyes total) reported corneal graft failure resulting in repeat penetrating keratoplasty (PKP) in 11 of 31 (35%) eyes with corneal grafts. Improper anterior chamber tube entry may damage the cornea. If the entry angle is not parallel to the iris and aims anteriorly, the needle used to create the tunnel may tear or detach Descemet’s membrane. Entry through the cornea (rather than the sclera) may also predispose to epithelial downgrowth or tube extrusion. To avoid such a complication, fullthickness entry into the anterior chamber should be as far posterior as possible.


Sign in / Sign up

Export Citation Format

Share Document